Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Alpha Tau Medical Ltd. Class A Ordinary Shares
DRTS | US
7.29
USD-0.06
-0.82%
DRTS | US
About Alpha Tau Medical Ltd. Class A Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
10/04/2026
Close
7.29
Open
7.34
High
7.38
Low
7.14
Alpha Tau Medical Ltd. a clinical-stage oncology therapeutics company engages in research development and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin oral pancreatic prostate and breast cancers; and preclinical studies for brain hepatic cell carcinoma glioblastoma multiforme lung cancer and others. The company was incorporated in 2015 and is headquartered in Jerusalem Israel.
View LessDRTS | US
Risk
45.7
Sharpe
2.90
Luna's Score
66/100
Recommendation
Buy
Luna says (DRTS | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
56.2%1 month
45.7%3 months
78.8%6 months
76.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.13
Debt to equity
0.17
Debt to assets
0.13
Ent. to EBITDA
-4.77
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-35.22M
MarketCap
509.75M
MarketCap(USD)
509.75M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-33.17
Short ratio
1.60
Short perc.
0.08
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
1.30
Range1M
1.35
Range3M
2.50
Volumes: Market Activity
Rel. volume
0.56
Price X volume
871.72K
